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Background
The metabotropic glutamate receptor, subtype 5
(GRM5) regulates cell excitability and neurotransmission
and has been suggested to play a modifying role in sev-
eral neuropsychiatric and neurodegenerative disorders,
including Parkinson’s disease (PD). The observation that
GRM5 inhibitors ameliorate symptoms and slow the
degradation of nigrostriatal dopamine neurons in rodent
models of PD suggests that low expression of GRM5
may also reduce symptoms in human patients and, pos-
sibly, slow the development of the disease. The goal of
the present study is quantify common variation of
GRM5 mRNA expression in human brain and identify
haplotypes or combinations of genotypes that correlate
with mRNA expression. Haplotypes and genotype com-
binations that predict mRNA expression should be use-
ful as markers in genetic association studies aimed at
detecting possible contributions of GRM5 to PD and
other disorders.
Methods
Sixty-three independent frozen sections of prefrontal
cortex (Han Chinese; Brodmann area 46) were obtained
from the China Brain Bank Center (Wuhan). Genomic
DNA and total RNA were isolated using standard proce-
dures. A common SNP, rs566277 (heterozygosity =
0.42), located within the 3’-untranslated region of GRM5
mRNA was chosen as a molecular marker to distinguish
mRNAs derived from each autosomal allele. SNaPShot©-
based AEI assays were carried out as previously
described [Lim J et al., Molecular Psychiatry, 2007].
Analysis of population distributions of log2AEI ratios
was carried out using a mathematical model developed
in-house. Levels of GRM5 mRNA relative to mRNA
encoding the house-keeping gene GAPDH were quanti-
fied using real-time PCR (calculated as ΔCt). Genome-
wide genotyping of samples was carried out using
HumanOmni1-Qad arrays (Illumina). SNPs for which
allelic heterozygosity and homozygosity correlate with
AEI were identified by calculating Kappa coefficients for
single-, double-, and triple- combinations of SNPs
within a 500,000 base pair region of chromosome 11
centered on GRM5. SNPs with genotypes that correlate
with GRM5 mRNA expression were identified by one-
way ANOVA analysis for SNPs in same region.
Results
Eleven of 18 samples heterozygous for the marker SNP
showed robust differential expression between alleles.
Mathematical modeling of the population distribution of
log2AEI ratios suggested that GRM5 mRNA is regulated
by two cis-acting genetic elements that are partially
linked to the marker SNP (D’ = 0.24) and tightly linked
with each other (D’ = 1.0). Three sets of tightly linked
SNPs located in immediate the 5’-upstream region
(rs7120151 + rs12421343 or rs4378401 or rs496939)
were found to fit this model (r-squared ~ 0.9 for pre-
dicted vs experimentally determined log2AEI population
distributions) and to be highly correlated with AEI
(Kappa coefficient = 0.75 for rs7120151 + rs12421343 or
rs4378401, and 0.5 for rs7120151 + rs496939). Correla-
tions between genotype and relative GRM5 mRNA
expression for rs7120151 and rs496939 just missed sta-
tistical significance (P = 0.05 – 0.057), but were statisti-
cally significant for the tightly linked SNPs rs655683
and rs7126679 (P = 0.035 and 0.03).* Correspondence: saffen@fudan.edu.cn
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Conclusions
Our study suggests that expression of GMR5 mRNA is
regulated by two tightly linked genetic elements located
within a 77 kb region centered on the exon 1 and the
promoter region. SNPs that highly correlate with AEI
and mRNA expression should provide useful markers in
genetic association studies aimed at evaluating the
potential role of GRM5 as a genetic modifier of neurop-
sychiatric and neurodegenerative disorders, including
PD.
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